From Selling Pills to Selling Health Care

As the pharmaceutical industry embarks on a dramatic shift from "selling pills" to "selling better health outcomes," drug manufacturers are increasingly focused on improving adherence to therapy and supporting patient wellness.

June 30, 2009

3:10 pm

Click here to view on demand

As the pharmaceutical industry embarks on a dramatic shift from “selling pills” to “selling better health outcomes,” drug manufacturers are increasingly focused on improving adherence to therapy and supporting patient wellness. To date, industry efforts to improve patient outcomes have been fragmented as drug marketers experiment with different adherence tactics through various channels. However, a more comprehensive approach that engages all stakeholders—patients, caregivers, physicians, pharmacists and payors—is needed to help patients achieve better health. Join us for an informative session featuring three industry experts who will examine the patient outcomes challenge and outline a new strategic model for moving forward.

Featured speakers
Dennis Urbaniak, VP of Innovation and New Customer Channels, Sanofi-Aventis
Daniel Hawkins, Founding Member, Clarion Healthcare Consulting
Dan Rubin, President, inVentiv Patient Outcomes

Moderator
James Chase, Editor-in-Chief, Medical Marketing & Media